| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 14,0 M € | -23.2% | 18,2 M € | -6.3% | 19,4 M € | +7.3% | 18,1 M € | +13.1% | 16,0 M € | +20.8% | 13,2 M € | -16.8% | 15,9 M € | -3.0% | 16,4 M € | +325.5% | 3,9 M € | +4.8% | 3,7 M € | -2.0% | 3,8 M € | +11.2% | 3,4 M € | -2.2% | 3,5 M € | -7.6% | 3,7 M € | +5.7% | 3,5 M € | -2.3% | 3,6 M € | |
| EBITDA | 968,5 k € | -7.7% | 1,0 M € | -13.2% | 1,2 M € | +43.2% | 844,5 k € | -15.9% | 1,0 M € | +130.0% | 436,6 k € | -51.1% | 892,3 k € | +12.7% | 791,5 k € | +4.6% | 756,7 k € | -4.3% | 791,1 k € | -8.3% | 862,4 k € | +30.1% | 662,7 k € | +15.7% | 572,6 k € | -34.7% | 876,6 k € | +11.0% | 789,9 k € | -4.8% | 829,4 k € | |
| Operating profit | 893,8 k € | -5.6% | 946,7 k € | -13.2% | 1,1 M € | +52.9% | 713,3 k € | -21.5% | 908,4 k € | +162.0% | 346,7 k € | -57.2% | 810,4 k € | +15.8% | 700,1 k € | +4.1% | 672,5 k € | -5.6% | 712,3 k € | -8.9% | 781,6 k € | +35.1% | 578,5 k € | +13.7% | 508,9 k € | -36.8% | 804,9 k € | +13.9% | 706,7 k € | -6.8% | 758,6 k € | |
| Profit/loss | 573,1 k € | -37.6% | 917,9 k € | +28.7% | 713,3 k € | +31.7% | 541,5 k € | +20.3% | 450,3 k € | +123.2% | 201,8 k € | -49.3% | 397,7 k € | -8.9% | 436,6 k € | +30.7% | 333,9 k € | -16.2% | 398,3 k € | -12.1% | 453,1 k € | +62.7% | 278,5 k € | +14.9% | 242,4 k € | -37.0% | 384,6 k € | +4.1% | 369,6 k € | -14.0% | 430,0 k € | |
| Equity | 5,3 M € | +12.2% | 4,7 M € | +24.3% | 3,8 M € | +23.2% | 3,1 M € | +21.4% | 2,5 M € | +21.7% | 2,1 M € | +10.8% | 1,9 M € | +26.9% | 1,5 M € | +41.9% | 1,0 M € | +47.1% | 708,4 k € | 0.0% | 708,4 k € | 0.0% | 708,4 k € | 0.0% | 708,4 k € | 0.0% | 708,4 k € | 0.0% | 708,4 k € | 0.0% | 708,4 k € | |
| Total assets | 9,8 M € | +24.9% | 7,9 M € | -14.0% | 9,2 M € | -1.4% | 9,3 M € | +16.2% | 8,0 M € | +17.7% | 6,8 M € | -11.9% | 7,7 M € | +4.6% | 7,4 M € | +41.6% | 5,2 M € | -7.1% | 5,6 M € | -2.0% | 5,7 M € | +33.4% | 4,3 M € | -9.3% | 4,7 M € | -17.6% | 5,7 M € | +13.9% | 5,0 M € | -8.7% | 5,5 M € | |
| Debts | 4,2 M € | +51.5% | 2,8 M € | -45.6% | 5,1 M € | -13.1% | 5,8 M € | +11.2% | 5,3 M € | +16.8% | 4,5 M € | -18.8% | 5,5 M € | -1.7% | 5,6 M € | +41.4% | 4,0 M € | -16.2% | 4,8 M € | -1.3% | 4,8 M € | +41.9% | 3,4 M € | -8.6% | 3,7 M € | -24.2% | 4,9 M € | +17.7% | 4,2 M € | -10.8% | 4,7 M € | |
| Staff | 29 | 36,7 | 39,7 | 38,9 | 36,6 | 32,2 | 29,4 | 27,5 | 27,2 | 27,6 | 24,8 | 23,4 | 22,7 | 23,7 | 21,8 | 19 | ||||||||||||||||
Private limited company · Vilvoorde · incorporated on 19/01/2000 · 29,0 ETP
Private limited company profitable and well capitalised.
Solid counterparty for a standard engagement.
EDWARDS LIFESCIENCES BELGIUM is a Private limited company incorporated in 2000. Its main activity is: Manufacture of medical and dental instruments and supplies. Its registered office is in Vilvoorde. It employs on average 29,0 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette